AstraZeneca’s subcutaneous Saphnelo application rejected by FDA, delaying approval until 2026. However, it remains approved in the EU for treating lupus patients.
.png)
Novo Nordisk said today that its next-generation obesity drug CagriSema delivered better weight loss and blood sugar control than Wegovy in a late-stage diabetes trial, strengthening its pipeline in the fast-growing market.
Biocon Biologics has secured a credit rating upgrade from S&P Global Ratings to BB+, reflecting a simpler capital structure, improved financial discipline, and steady growth outlook in the global biosimilars market.
Piramal Pharma said it is seeing early signs of recovery in its CDMO business, driven by higher RFP activity and improving US biotech funding, even as inventory destocking continued to weigh on Q3FY26 results.c
.png)
Eli Lilly has entered a deal worth up to $1.12 billion with gene-editing firm Seamless Therapeutics, signaling a major push into advanced genetic treatments for hearing loss and rare diseases.
Zydus Lifesciences said its Ankleshwar manufacturing facility received three observations from the USFDA after a recent inspection, adding that none of the findings were linked to data integrity issues.
Wellness initiatives enhance employee performance by improving health focus and engagement while fostering long-term community health through reduced disease burdens and stronger social ties.
Merck has partnered with a global health coalition to improve access to its Ebola vaccine, aiming to reduce costs and ensure availability in regions most affected by the virus. The initiative focuses on saving lives and controlling outbreaks.
Abbott has received CE Mark approval for its TactiFlex Duo Ablation Catheter in Europe, marking a major step forward in AFib treatment with dual-energy technology and successful first commercial cases.
Dentalkart partners with NSK Japan to offer authentic dental equipment in India with transparent pricing and faster after-sales support.
.jpg)
.jpg)
, CDSCO.jpg)